Clinical Trial Update: Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing gastric antral injections of botulinum toxin for obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity | Phase 1 | Status: COMPLETED